Sirius Medical Celebrates the Enrollment of the First Patient in the MELODY Study with Pintuition®
EINDHOVEN, Netherlands, Jan. 24, 2024 /PRNewswire/ -- Sirius Medical is proud to celebrate the enrollment of the first patient in the MELODY Study using the innovative Sirius Pintuition System by Prof. Dr. Banys-Paluchowski.
- EINDHOVEN, Netherlands, Jan. 24, 2024 /PRNewswire/ -- Sirius Medical is proud to celebrate the enrollment of the first patient in the MELODY Study using the innovative Sirius Pintuition System by Prof. Dr. Banys-Paluchowski.
- The MELODY study, officially known as "MELODY - MEthods for LOcalization of Different types of breast lesions," is a prospective, international, non-interventional multicenter cohort study.
- The study represents a significant effort to validate novel breast cancer treatments offering a more refined and patient-centric approach to tumor localization.
- If you are interested in joining the MELODY Study with Sirius Pintuition, you can contact Massimiliano Malloni, Clinical and Medical Affairs Director at [email protected] .